Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |